Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
Clin Mol Hepatol. 2023;29(2):417-432.   Published online 2022 Nov 21     DOI:
Citations to this article as recorded by Crossref logo
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine.2024; 95: 101231.     CrossRef
Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications
Ziwei Guo, Qinjuan Wu, Pengfei Xie, Jiuchong Wang, Wenliang Lv
Frontiers in Immunology.2024;[Epub]     CrossRef
The Important Roles of Natural Killer Cells in Liver Fibrosis
Ming Yang, Ethan Vanderwert, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Guangfu Li
Biomedicines.2023; 11(5): 1391.     CrossRef
Dysfunctions of Circulating Adaptive Immune Cells in End-Stage Liver Disease
Tong Liu, Yasmina Chouik, Fanny Lebossé, Wafa Khamri
Livers.2023; 3(3): 369.     CrossRef